Longevity Wearables Compared: Oura vs Whoop vs Ultrahuman vs Apple Watch
Four of the most-used longevity-tracker wearables, benchmarked against the same criteria: which biological-age score they report, HRV methodology, sleep and VO2max validation, cost of ownership, and battery life. Grounded in the wearable-validation literature and cross-referenced with the clinical trials we index inside LongevityHub Pro.
What a longevity wearable actually measures
A longevity wearable is any continuous sensor that estimates biological-age proxies from dynamic physiology — heart rate variability (HRV), resting heart rate (RHR), VO2max, and sleep architecture. Unlike an epigenetic clock test, a wearable does not measure biological age directly. It measures the physiological signals that biological age correlates with — and it measures them 24/7.
The four devices below dominate the consumer longevity-tracker market in 2026. Each takes a different position on the tradeoff between measurement continuity, form factor, and subscription cost.
The four metrics that matter
Resting heart rate & HRV
Lower RHR and higher HRV are among the strongest wearable-observable predictors of all-cause mortality. Overnight measurement (Oura, Ultrahuman) is cleaner than daytime sampling (Apple Watch).
VO2max
The single most-validated fitness biomarker for longevity. Apple Watch's estimation is the closest to lab-grade of any consumer device; Whoop derives it from workouts.
Sleep architecture
Deep sleep and REM percentages are moderately validated proxies for recovery. All four devices report sleep stages; Oura's ring position has the smallest motion-artifact error.
Composite 'age' scores
Cardiovascular Age (Oura), Whoop Age, and Ultrahuman's Age Metric are proprietary composites. Directionally useful for tracking self-experiments; not comparable across brands.
Side-by-side comparison
All prices in USD, as listed by the vendor at time of writing. "Peer-reviewed" means the device's HRV or sleep-staging accuracy has been evaluated in a published validation study.
| Wearable | Bio-age score | HRV method | VO2max | Battery | Price | Subscription | Peer-reviewed |
|---|---|---|---|---|---|---|---|
Oura Ring Gen 4 Oura · Ring (titanium) | Cardiovascular Age (via HRV, RHR, arterial stiffness proxy) | Nightly rMSSD (infrared PPG, finger artery) | 5–7 days | $349–$499 | $5.99/mo required for full metrics | ||
Whoop 5.0 / MG Whoop · Wristband (screenless) | Whoop Age (composite of HRV, RHR, VO2max, activity) | Continuous PPG, ~24h sampling | 4–5 days | $0 hardware (membership only) | $239/yr (One) to $359/yr (Life) | ||
Ultrahuman Ring Air Ultrahuman · Ring (titanium) | PhoenixOS 'Age Metric' (HRV, glucose*, movement) | Nightly PPG windows | 4–6 days | $349 | No subscription (CGM integration extra) | ||
Apple Watch Series 10 / Ultra 2 Apple · Smartwatch | None (Cardio Fitness + VO2max only) | Intermittent SDNN samples during Breathe / Mindfulness | 18h (S10) / 36h (Ultra 2) | $399–$799 | None |
Best-in-class overnight HRV and sleep-stage validation. Cardiovascular Age is the most transparent biological-age proxy on a consumer wearable.
Highest-frequency HRV of the four. Whoop Age is opaque methodologically but tracks intervention responses in weeks.
Only ring with native CGM integration (Ultrahuman M1). Age metric is less validated than Oura's but no ongoing subscription is compelling.
Best VO2max estimation on a consumer wrist device — the single strongest all-cause-mortality predictor here. HRV cadence is too sparse for daily readiness scoring.
What the evidence says
Across UK Biobank and NHANES cohorts, VO2max is the single strongest wearable-observable predictor of all-cause mortality — a hazard ratio of roughly 0.55 per SD in cardiorespiratory fitness. This is where the Apple Watch, and to a lesser extent Whoop, have a measurable edge over rings, which cannot estimate VO2max directly.
Overnight HRV (Oura, Ultrahuman) captures the cleanest parasympathetic signal because motion and thermal noise are minimal during sleep. Continuous wrist PPG (Whoop) trades per-sample accuracy for temporal density, which is what makes its within-person trend lines responsive to short-term interventions.
Composite "age" scores (Cardiovascular Age, Whoop Age, Age Metric) should be read as within-device trend lines, not cross-comparable numbers. A 2-year drop in Whoop Age does not mean the same thing as a 2-year drop in Oura's Cardiovascular Age — the underlying formulas are proprietary and diverge on which inputs they weight most.
LongevityHub Pro tracks clinical trials using wearable HRV, VO2max, and sleep as endpoints, and indexes research on wearable validation as it appears — including the ongoing debate over how much of a composite-age score reflects real biology versus branded reweighting of familiar inputs.
How to choose a longevity wearable
Frequently asked questions
Which longevity wearable is the most accurate in 2026?
For the biological-age markers with the strongest mortality evidence — resting heart rate, HRV, and VO2max — the Apple Watch Ultra 2 (VO2max), Oura Ring Gen 4 (overnight HRV/RHR), and Whoop 5.0 (continuous HRV) each lead in a different dimension. Serious longevity trackers typically pair one continuous device (Whoop or Oura) with an Apple Watch for VO2max.
Do any wearables actually measure biological age?
No consumer wearable measures biological age directly. Oura's Cardiovascular Age, Whoop Age, and Ultrahuman's Age Metric are composite scores derived from HRV, RHR, and activity — proxies, not epigenetic clocks. For validated biological age, pair a wearable with an epigenetic test (see our biological age testing guide).
Is subscription-based (Whoop) or one-time (Oura, Ultrahuman) better value?
Over three years, Whoop Life ($359/yr × 3 = $1,077) is more expensive than Oura ($399 hardware + $216 subscription = $615) or Ultrahuman (~$349 with no subscription). Whoop's advantage is that hardware upgrades are included; Oura's Gen 4 will require repurchase for the next generation.
How accurate is wearable HRV vs a chest strap ECG?
Overnight PPG HRV (Oura, Ultrahuman) shows correlations of r = 0.85–0.95 with ECG rMSSD in validation studies. Continuous wrist PPG (Whoop) is slightly lower (~0.80). All four are more than adequate for tracking within-person trends; none should be used for clinical arrhythmia detection.
Can a wearable replace an epigenetic clock test?
No. Wearables track dynamic physiology (readiness, recovery, cardiovascular fitness); epigenetic clocks like DunedinPACE and GrimAge measure long-run biological aging trajectory. They answer different questions and are best used together.
Track the science, not just your score
LongevityHub Pro indexes every clinical trial, funding round, and peer-reviewed study behind the wearables above. See what's working — and what's not — before the next headline.
Start free trialThis guide is for informational purposes only and is not medical advice. Consumer wearables are not FDA-approved diagnostics. Consult a qualified clinician before making health decisions based on any tracker output.